Article citationsMore>>
M. S. Niederman, L. A. Mandell, A. Anzueto, J. B. Bass, W. A. Broughton, G. D. Campbell, N. Dean, T. File, M. J. Fine, P. A. Gross, F. Martinez, T. J. Marrie, J. F. Plouffe, J. Ramirez, G. A. Sarosi, A. Torres, R. Wilson and V. L. Yu, “Guide Lines for the Management of Adults with Community-Acquired Pneumonia. Diagnosis, Assessment of Severity, Antimicrobial Therapy, and Prevention,” American Journal of Respiratory and Critical Care Medicine, Vol. 163, No. 7, 2001, pp. 1730-1754.
has been cited by the following article:
-
TITLE:
Corticosteroids and ICU Course of Community Acquired Pneumonia in Egyptian Settings
AUTHORS:
Nirmeen A. Sabry, Emad El-Din Omar
KEYWORDS:
Community-Acquired Pneumonia, Corticosteroids, Hydrocortisone, Pneumonia
JOURNAL NAME:
Pharmacology & Pharmacy,
Vol.2 No.2,
March
30,
2011
ABSTRACT: Background: Pneumonia is the most common cause of community-acquired infection requiring ICU admission. 60-87% of patients with severe community acquired pneumonia (CAP) admitted to the ICU develops respiratory failure and require mechanical ventilation (MV). Objectives: To assess the efficacy and safety of adjunctive low dose hydrocortisone infusion treatment in Egyptian ICU patients with CAP. Methods: Hospitalized patients, clinically and radiologically diagnosed with CAP, were randomized to receive hydrocortisone 12.5 mg/h IV infusion for 7 days or placebo, along with antibiotics. The end-points of the study were improvement in PaO2:FIO2 (PaO2:FIO2 > 300 or ≥100 increase from study entry) and SOFA score by study day 8 and the development of delayed septic shock. Results: 80 patients were recruited, 40 of them received hydrocortisone and the remaining 40 received placebo. By study day 8, hydrocortisone treated patients showed a significant improvement in PaO2:FIO2 and chest radiograph score, and a significant reduction in C-reactive protein (CRP) levels, Sepsis-related Organ Failure Assessment (SOFA) score, and delayed septic shock compared to the control group. Hydrocortisone treatment was associated with a significant reduction in the duration of MV. However, hydrocortisone infusion did not show significant difference in the ICU mortality. Conclusions: adjunctive 7-day course of low dose hydrocortisone IV in patients with CAP hastens recovery of pneumonia and prevents the development of sepsis related complications with a significant reduction in duration of the mechanical ventilation.
Related Articles:
-
Erdmann Görg
-
Jai Dev Chandel, Nand Lal Singh
-
Moawwad E. A. El-Mikkawy
-
Fifonsi Ayélé Dangbo, Kossi Adjonou, Kouami Kokou, Juergen Blaser
-
Vaibhav W. Godse, Sahebrao S. Rindhe, Laszlo Kotai, Pravin S. Kendrekar, Rajendra P. Pawa